Autoregulation	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
transactivator	I-protein
RelA	B-protein
(	O
p65	B-protein
)	O
by	O
multiple	O
cytoplasmic	B-protein
inhibitors	I-protein
containing	O
ankyrin	B-protein
motifs	I-protein
.	O

RelA	B-protein
(	O
p65	B-protein
)	O
functions	O
as	O
the	O
critical	O
transactivating	O
component	O
of	O
the	O
heterodimeric	B-protein
p50-p65	I-protein
NF-kappa	I-protein
B	I-protein
complex	I-protein
and	O
contains	O
a	O
high-affinity	B-protein
binding	I-protein
site	I-protein
for	O
its	O
cytoplasmic	B-protein
inhibitor	I-protein
,	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

After	O
cellular	O
activation	O
,	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
is	O
rapidly	O
degraded	O
in	O
concert	O
with	O
the	O
induced	O
nuclear	O
translocation	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

The	O
present	O
study	O
demonstrates	O
that	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
-induced	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
is	O
preceded	O
by	O
its	O
rapid	O
phosphorylation	O
in	O
vivo	O
.	O

However	O
,	O
these	O
effects	O
on	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
result	O
in	O
nuclear	O
mobilization	O
of	O
only	O
a	O
fraction	O
of	O
the	O
entire	O
cytoplasmic	O
pool	O
of	O
RelA	B-protein
.	O

Subsequent	O
studies	O
have	O
revealed	O
that	O
(	O
i	O
)	O
cytoplasmic	B-protein
RelA	I-protein
is	O
stably	O
associated	O
not	O
only	O
with	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
but	O
also	O
with	O
other	O
ankyrin	B-protein
motif-rich	I-protein
proteins	I-protein
including	O
the	O
products	O
of	O
the	O
NF-kappa	B-DNA
B2	I-DNA
(	I-DNA
p100	I-DNA
)	I-DNA
and	I-DNA
NF-kappa	I-DNA
B1	I-DNA
(	I-DNA
p105	I-DNA
)	I-DNA
genes	I-DNA
;	O
(	O
ii	O
)	O
in	O
contrast	O
to	O
RelA	B-protein
-I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
,	O
RelA-p100	B-protein
cytoplasmic	I-protein
complexes	I-protein
are	O
not	O
dissociated	O
following	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
activation	O
;	O
(	O
iii	O
)	O
p100	B-protein
functions	O
as	O
a	O
potent	O
inhibitor	O
of	O
RelA	B-protein
-mediated	O
transcription	O
in	O
vivo	O
;	O
(	O
iv	O
)	O
the	O
interaction	O
of	O
RelA	B-protein
and	O
p100	B-protein
involves	O
the	O
conserved	B-protein
Rel	I-protein
homology	I-protein
domain	I-protein
of	O
both	O
proteins	O
but	O
not	O
the	O
nuclear	B-protein
localization	I-protein
signal	I-protein
of	O
RelA	B-protein
,	O
which	O
is	O
required	O
for	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
binding	O
;	O
(	O
v	O
)	O
p100	B-protein
inhibition	O
of	O
RelA	B-protein
function	O
requires	O
the	O
C-terminal	B-protein
ankyrin	I-protein
motif	I-protein
domain	I-protein
,	O
which	O
mediates	O
cytoplasmic	O
retention	O
of	O
RelA	B-protein
;	O
and	O
(	O
vi	O
)	O
as	O
observed	O
with	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
,	O
nuclear	O
RelA	B-protein
stimulates	O
p100	B-RNA
mRNA	I-RNA
and	O
protein	O
expression	O
.	O

These	O
findings	O
thus	O
reveal	O
the	O
presence	O
of	O
a	O
second	O
inducible	O
autoregulated	O
inhibitory	O
pathway	O
that	O
helps	O
ensure	O
the	O
rapid	O
but	O
transient	O
action	O
of	O
nuclear	B-protein
NF-kappa	I-protein
B	I-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

91	NULL
,	NULL
pp	NULL
.	NULL

1346-1350	NULL
,	NULL
February	NULL
1994	NULL
Biochemistry	NULL
Autoregulation	NULL
of	NULL
the	NULL
transactivator	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
Snao-Cong	NULL
SUN*	NULL
,	NULL
PaARKHAM	NULL
A.	NULL
GaNcHI*	NULL
,	NULL
CHRISTOPHE	NULL
BERAUD*	NULL
,	NULL
DEAN	NULL
W.	NULL
BALLARD	NULL
,	NULL
AND	NULL
WARNER	NULL
C.	NULL
*Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
419100	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94141-9100	NULL
;	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
,	NULL
802	NULL
Light	NULL
Hall	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-0295	NULL
Communicated	NULL
by	NULL
Ira	NULL
Herskowitz	NULL
,	NULL
August	NULL
26	NULL
,	NULL
1993	NULL
(	NULL
received	NULL
for	NULL
review	NULL
May	NULL
28	NULL
,	NULL
1993	NULL
)	NULL
ABSTRACT	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
functions	NULL
as	NULL
the	NULL
critical	NULL
trans-activating	NULL
component	NULL
of	NULL
the	NULL
heterodimeric	NULL
pS50O-p65	NULL
NF-xB	NULL
complex	NULL
and	NULL
contains	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
for	NULL
its	NULL
cytoplasmic	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
.	NULL

After	NULL
cellular	NULL
activation	NULL
,	NULL
IxBa	NULL
is	NULL
rapidly	NULL
degraded	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
tumor	NULL
necrosis	NULL
factor	NULL
-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
is	NULL
preceded	NULL
by	NULL
its	NULL
rapid	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
these	NULL
effects	NULL
on	NULL
IxcBax	NULL
result	NULL
in	NULL
nuclear	NULL
mobilization	NULL
of	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
entire	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
RelA	NULL
.	NULL

Subsequent	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
(	NULL
i	NULL
)	NULL
cytoplasmic	NULL
RelA	NULL
is	NULL
stably	NULL
associated	NULL
not	NULL
only	NULL
with	NULL
IxBa	NULL
but	NULL
also	NULL
with	NULL
other	NULL
ankyrin	NULL
motif-rich	NULL
proteins	NULL
including	NULL
the	NULL
products	NULL
of	NULL
the	NULL
NF-xB2	NULL
(	NULL
p100	NULL
)	NULL
and	NULL
NF-xB1	NULL
(	NULL
p105	NULL
)	NULL
genes	NULL
;	NULL
(	NULL
i	NULL
?	NULL
)	NULL

in	NULL
contrast	NULL
to	NULL
RelA-IxBa	NULL
,	NULL
RelA	NULL
,	NULL
p100	NULL
cytoplasmic	NULL
complexes	NULL
are	NULL
not	NULL
dissociated	NULL
following	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
activation	NULL
;	NULL
(	NULL
i	NULL
)	NULL
p100	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
RelA-mediated	NULL
transcription	NULL
in	NULL
vivo	NULL
;	NULL
(	NULL
iv	NULL
)	NULL
the	NULL
interaction	NULL
of	NULL
RelA	NULL
and	NULL
p100	NULL
involves	NULL
the	NULL
conserved	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
both	NULL
proteins	NULL
but	NULL
not	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
RelA	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
IxBa	NULL
binding	NULL
;	NULL
(	NULL
v	NULL
)	NULL
p100	NULL
inhibition	NULL
of	NULL
RelA	NULL
function	NULL
requires	NULL
the	NULL
C-terminal	NULL
ankyrin	NULL
motif	NULL
domain	NULL
,	NULL
which	NULL
mediates	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
RelA	NULL
;	NULL
and	NULL
(	NULL
vi	NULL
)	NULL
as	NULL
observed	NULL
with	NULL
IxBa	NULL
,	NULL
nuclear	NULL
RelA	NULL
stimulates	NULL
p100	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
reveal	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
second	NULL
inducible	NULL
autoregulated	NULL
inhibitory	NULL
pathway	NULL
that	NULL
helps	NULL
ensure	NULL
the	NULL
rapid	NULL
but	NULL
transient	NULL
action	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
.	NULL

The	NULL
mammalian	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
and	NULL
multiple	NULL
cellular	NULL
genes	NULL
that	NULL
contain	NULL
functional	NULL
«	NULL
B	NULL
enhancer	NULL
elements	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

NF-KB	NULL
is	NULL
an	NULL
inducible	NULL
heterodimeric	NULL
complex	NULL
composed	NULL
of	NULL
50-kDa	NULL
(	NULL
p50	NULL
)	NULL
and	NULL
65-kDa	NULL
(	NULL
p65	NULL
,	NULL
now	NULL
designated	NULL
RelA	NULL
)	NULL
subunits	NULL
(	NULL
3-11	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
share	NULL
an	NULL
region	NULL
of	NULL
N-terminal	NULL
homology	NULL
with	NULL
the	NULL
v-Rel	NULL
oncoprotein	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
RelA	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
contains	NULL
a	NULL
strong	NULL
transcriptional	NULL
activation	NULL
domain	NULL
and	NULL
an	NULL
intrinsic	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
that	NULL
is	NULL
recognized	NULL
and	NULL
masked	NULL
by	NULL
IxBa	NULL
(	NULL
previously	NULL
termed	NULL
MAD-3	NULL
)	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
a	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
contains	NULL
multiple	NULL
ankyrin	NULL
or	NULL
SW16-cdc10	NULL
motifs	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Cellular	NULL
activation	NULL
appears	NULL
to	NULL
lead	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
followed	NULL
by	NULL
the	NULL
rapid	NULL
dissociation	NULL
and	NULL
degradation	NULL
of	NULL
this	NULL
cytoplasmic	NULL
inhibitor	NULL
,	NULL
concomitant	NULL
with	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
liberated	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
stimulates	NULL
the	NULL
transcription	NULL
of	NULL
an	NULL
array	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
such	NULL
diverse	NULL
functions	NULL
as	NULL
immune	NULL
activation	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
development	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
14	NULL
)	NULL
.	NULL

During	NULL
this	NULL
induced	NULL
genetic	NULL
program	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
also	NULL
activates	NULL
expression	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
,	NULL
thus	NULL
facilitating	NULL
an	NULL
autoregulatory	NULL
feedback	NULL
mechanism	NULL
that	NULL
serves	NULL
to	NULL
temporally	NULL
restrict	NULL
NF-	NULL
«	NULL
B	NULL
action	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

$	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

1346	NULL
Recent	NULL
reports	NULL
have	NULL
revealed	NULL
that	NULL
RelA	NULL
can	NULL
also	NULL
associate	NULL
with	NULL
yet	NULL
other	NULL
ankyrin	NULL
motif-rich	NULL
cytoplasmic	NULL
proteins	NULL
distinct	NULL
from	NULL
IxBa	NULL
,	NULL
including	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p105	NULL
)	NULL
and	NULL
NF-	NULL
«	NULL
B2	NULL
(	NULL
p100	NULL
)	NULL
precursor	NULL
gene	NULL
products	NULL
,	NULL
which	NULL
are	NULL
subsequently	NULL
cleaved	NULL
to	NULL
produce	NULL
the	NULL
p50	NULL
and	NULL
p52	NULL
Rel	NULL
family	NULL
members	NULL
,	NULL
respectively	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
these	NULL
interactions	NULL
in	NULL
vivo	NULL
remains	NULL
unclear	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
explored	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
structural	NULL
basis	NULL
and	NULL
functional	NULL
consequences	NULL
of	NULL
RelA	NULL
interaction	NULL
with	NULL
the	NULL
ankyrin	NULL
motif-rich	NULL
p100	NULL
and	NULL
p105	NULL
Rel-containing	NULL
precursors	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Transient	NULL
Transfection	NULL
Assays	NULL
.	NULL

All	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pCMV4	NULL
expression	NULL
vector	NULL
(	NULL
24	NULL
)	NULL
.	NULL

N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
RelA	NULL
and	NULL
p100	NULL
were	NULL
generated	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
from	NULL
the	NULL
corresponding	NULL
full-length	NULL
cDNAs	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
«	NULL
B-TATA-CAT	NULL
contained	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
linked	NULL
upstream	NULL
of	NULL
the	NULL
Escherichia	NULL
coli	NULL
chloramphenicol	NULL
acetyitransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
and	NULL
transfected	NULL
with	NULL
effector	NULL
and	NULL
reporter	NULL
plasmids	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
26	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
Immunoblotting	NULL
,	NULL
and	NULL
Immunofluorescence	NULL
Studies	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
26	NULL
)	NULL
.	NULL

After	NULL
48	NULL
hr	NULL
,	NULL
recipient	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
methionine/cysteine-deficient	NULL
medium	NULL
and	NULL
metabolically	NULL
radiolabeled	NULL
for	NULL
2	NULL
hr	NULL
with	NULL
[	NULL
**S	NULL
)	NULL
methionine	NULL
and	NULL
[	NULL
**S	NULL
}	NULL
cysteine	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysis	NULL
in	NULL
a	NULL
low-stringency	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipi-tation	NULL
analyses	NULL
with	NULL
the	NULL
indicated	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
IxB-specific	NULL
antisera	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Unlabeled	NULL
subcellular	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
transfected	NULL
COS	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

For	NULL
phosphorylation	NULL
analysis	NULL
,	NULL
the	NULL
cell	NULL
lysis	NULL
buffer	NULL
(	NULL
27	NULL
)	NULL
was	NULL
supplemented	NULL
with	NULL
0.4	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
0.1	NULL
mM	NULL
NaVO	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
uM	NULL
ZnCl	NULL
»	NULL
,	NULL
and	NULL
10	NULL
uM	NULL
sodium	NULL
molybdate	NULL
.	NULL

Protein	NULL
samples	NULL
(	NULL
20	NULL
ug	NULL
per	NULL
lane	NULL
for	NULL
Jurkat	NULL
and	NULL
4	NULL
pg	NULL
per	NULL
lane	NULL
for	NULL
COS	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
analyzed	NULL
for	NULL
immunoreactivity	NULL
with	NULL
various	NULL
anti-peptide	NULL
antisera	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
immunofluorescence	NULL
studies	NULL
,	NULL
COS	NULL
cells	NULL
were	NULL
grown	NULL
on	NULL
four-well	NULL
chamber	NULL
slides	NULL
(	NULL
Nunc	NULL
,	NULL
Naperville	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
then	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
.	NULL

After	NULL
48	NULL
hr	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
permeabilized	NULL
,	NULL
and	NULL
sequentially	NULL
incubated	NULL
with	NULL
rabbit	NULL
anti-RelA	NULL
(	NULL
C	NULL
terminus	NULL
specific	NULL
)	NULL
or	NULL
anti-p100	NULL
followed	NULL
by	NULL
donkey	NULL
anti-rabbit	NULL
immunoglobulin	NULL
covalently	NULL
coupled	NULL
to	NULL
Texas	NULL
Red	NULL
dye	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
HIV-1	NULL
,	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
NLS	NULL
,	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Biochemistry	NULL
:	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

RESULTS	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
-Induced	NULL
Degradation	NULL
of	NULL
IxBa	NULL
Is	NULL
Preceded	NULL
by	NULL
IxBa	NULL
Phosphorylation	NULL
in	NULL
Vivo	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
detectable	NULL
within	NULL
10	NULL
min	NULL
after	NULL
TNF-a	NULL
stimulation	NULL
of	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
the	NULL
cytoplasmic	NULL
stores	NULL
of	NULL
IxBa	NULL
are	NULL
completely	NULL
depleted	NULL
between	NULL
10	NULL
and	NULL
40	NULL
min	NULL
after	NULL
TNF-a	NULL
addition	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
IxBa	NULL
was	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
prior	NULL
to	NULL
its	NULL
degradation	NULL
and	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-KB	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
0-10	NULL
min	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-I	NULL
«	NULL
Ba	NULL
specific	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

TNF-a	NULL
stimulation	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
low-mobility	NULL
isoform	NULL
of	NULL
IxBa	NULL
detected	NULL
within	NULL
5	NULL
min	NULL
after	NULL
induction	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Coincubation	NULL
of	NULL
these	NULL
TNF-a-stimulated	NULL
cells	NULL
with	NULL
okadaic	NULL
acid	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
protein	NULL
phosphatases	NULL
1	NULL
and	NULL
2A	NULL
(	NULL
28	NULL
)	NULL
and	NULL
an	NULL
inducer	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
29	NULL
)	NULL
,	NULL
temporally	NULL
accelerated	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
low-mobility	NULL
IxBa	NULL
isoform	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
perhaps	NULL
reflecting	NULL
the	NULL
unopposed	NULL
action	NULL
of	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
kinase	NULL
.	NULL

Under	NULL
both	NULL
conditions	NULL
of	NULL
stimulation	NULL
,	NULL
this	NULL
low-mobility	NULL
IxBa	NULL
isoform	NULL
disappeared	NULL
within	NULL
10	NULL
min	NULL
,	NULL
whereas	NULL
the	NULL
basally	NULL
expressed	NULL
IxBa	NULL
isoform	NULL
persisted	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
extracts	NULL
from	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
5	NULL
min	NULL
with	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
1347	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
revealed	NULL
the	NULL
selective	NULL
loss	NULL
of	NULL
this	NULL
transiently	NULL
expressed	NULL
IxBa	NULL
species	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
altered	NULL
mobility	NULL
reflected	NULL
phosphorylation	NULL
at	NULL
one	NULL
or	NULL
more	NULL
sites	NULL
.	NULL

RelA	NULL
Is	NULL
Associated	NULL
with	NULL
Multiple	NULL
Cytoplasmic	NULL
Proteins	NULL
,	NULL
Including	NULL
p100	NULL
and	NULL
p105	NULL
.	NULL

Even	NULL
after	NULL
the	NULL
intracellular	NULL
stores	NULL
of	NULL
IxBa	NULL
were	NULL
completely	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
TNF-a	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
substantial	NULL
amounts	NULL
of	NULL
RelA	NULL
remained	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
these	NULL
induced	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

18	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
RelA	NULL
might	NULL
be	NULL
regulated	NULL
by	NULL
additional	NULL
inhibitory	NULL
molecules	NULL
distinct	NULL
from	NULL
IxBa	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
possibility	NULL
,	NULL
control	NULL
preimmune	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
anti-RelA	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
coimmunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
electrophoresed	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
peptide-specific	NULL
antisera	NULL
against	NULL
the	NULL
ankyrin	NULL
motif-containing	NULL
proteins	NULL
p100	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
p105	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
as	NULL
well	NULL
as	NULL
IxBa	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
that	NULL
,	NULL
like	NULL
IxBa	NULL
,	NULL
both	NULL
p100	NULL
and	NULL
p105	NULL
were	NULL
readily	NULL
coimmunoprecipitated	NULL
with	NULL
RelA	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
deletion	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
physical	NULL
interaction	NULL
of	NULL
p100	NULL
and	NULL
p105	NULL
with	NULL
RelA	NULL
was	NULL
mediated	NULL
through	NULL
their	NULL
Rel	NULL
homology	NULL
domains	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
IxBa-RelA	NULL
A	NULL
TNFa	NULL
OA+TNFc	NULL
__	NULL
TNFa	NULL
5	NULL
min	NULL
B	NULL
I	NULL
U	NULL
1	NULL
I	NULL
1	NULL
ffifff	NULL
:	NULL
&	NULL
n	NULL
f	NULL
f	NULL
48.5	NULL
-	NULL
84.0	NULL
Gas	NULL
lins	NULL
.	NULL

a	NULL
“	NULL
(	NULL
Ba-é	NULL
wun	NULL
wi	NULL
vue	NULL
wp	NULL
<	NULL
-	NULL
<	NULL
4	NULL
p65	NULL
365-	NULL
-i	NULL
<	NULL
Bo	NULL
48.5	NULL
Alii	NULL
comon	NULL
wine	NULL
...	NULL
.	NULL

~-	NULL
-e-29.0	NULL
.	NULL

smut	NULL
36.5	NULL
-	NULL
IxBa	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
CLLR	NULL
o	NULL
,	NULL
``	NULL
-	NULL
ark/aka	NULL
kzkok	NULL
;	NULL
koko	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
B	NULL
2	NULL
22°n	NULL
t	NULL
2	NULL
,	NULL
22	NULL
A	NULL
``	NULL
chx	NULL
kz	NULL
-ai	NULL
.	NULL

se	NULL
6	NULL
’	NULL
0	NULL
’	NULL
0'04/0	NULL
4	NULL
)	NULL
’	NULL
0°	NULL
’	NULL
/	NULL
,	NULL
}	NULL
%	NULL
,	NULL
0	NULL
hr	NULL
0.5	NULL
hr	NULL
2	NULL
hr	NULL
%	NULL
.	NULL

Immunoblot	NULL
Anti-p100	NULL
Anti-p105	NULL
Anti-lBa	NULL
.	NULL

Immunoblot	NULL
Anti-p65	NULL
F	NULL
--	NULL
-	NULL
]	NULL
--	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
IP	NULL
Anti-lxBo	NULL
.	NULL

Anti-p100	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
o	NULL
e	NULL
r	NULL
--	NULL
]	NULL
»	NULL
,	NULL
-	NULL
48.5	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
116-	NULL
we-	NULL
»	NULL
p100	NULL
wt	NULL
«	NULL
-	NULL
P105	NULL
_|	NULL
=	NULL
16-0000	NULL
1__	NULL
J_	NULL
_|	NULL
84	NULL
_	NULL
IxBa*	NULL
_	NULL
p34	NULL
-	NULL
-36.5	NULL
[	NULL
mull	NULL
|	NULL
met	NULL
__	NULL
58	NULL
-	NULL
-29	NULL
°8~	NULL
ip	NULL
o	NULL
CL	NULL
L	NULL
L	NULL
d	NULL
So	NULL
So	NULL
So	NULL
:	NULL
So	NULL
So	NULL
S	NULL
An	NULL
T	NULL
27	NULL
On	NULL
27	NULL
OTs	NULL
T	NULL
TNFa	NULL
69.25	NULL
``	NULL
o	NULL
.	NULL

%	NULL
0	NULL
,	NULL
.°5	NULL
_o	NULL
ail	NULL
,	NULL
»	NULL
Q	NULL
Q	NULL
’	NULL
of	NULL
”	NULL
:	NULL
oo°	NULL
‘	NULL
o	NULL
«	NULL
gr/10690	NULL
ba	NULL
bp	NULL
Un	NULL
[	NULL
p	NULL
5	NULL
5	NULL
>	NULL
&	NULL
»	NULL
,	NULL
»	NULL
&	NULL
&	NULL
%	NULL
,	NULL
24s	NULL
0	NULL
,	NULL
o	NULL
*	NULL
%	NULL
,	NULL
``	NULL
o	NULL
``	NULL
*	NULL
,	NULL
o	NULL
*	NULL
``	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
vivo	NULL
in	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
of	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
at	NULL
50	NULL
ng/ml	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
140	NULL
units/ml	NULL
)	NULL
for	NULL
0-10	NULL
min	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
slightly	NULL
faster	NULL
kinetics	NULL
of	NULL
IxBa	NULL
degradation	NULL
seen	NULL
in	NULL
this	NULL
experiment	NULL
versus	NULL
ref	NULL
.	NULL

19	NULL
likely	NULL
reflects	NULL
TNF	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
at	NULL
a	NULL
lower	NULL
cell	NULL
density	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
were	NULL
fractionated	NULL
on	NULL
an	NULL
SDS/10	NULL
%	NULL
PAGE	NULL
gel	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
analyses	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
.	NULL

For	NULL
phosphatase	NULL
treatment	NULL
,	NULL
the	NULL
extract	NULL
from	NULL
lane	NULL
3	NULL
was	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
15	NULL
min	NULL
either	NULL
in	NULL
phosphatase	NULL
buffer	NULL
alone	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
or	NULL
in	NULL
buffer	NULL
containing	NULL
24	NULL
units	NULL
of	NULL
calf	NULL
intestine	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
CIP	NULL
;	NULL
lane	NULL
10	NULL
)	NULL
before	NULL
analysis	NULL
by	NULL
SDS/PAGE	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Subcellular	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
RelA	NULL
and	NULL
IxBa	NULL
in	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
140	NULL
units/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
;	NULL
25	NULL
ug/ml	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
extracts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
,	NULL
prepared	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
after	NULL
TNF-a	NULL
addition	NULL
,	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
SDS/8.75	NULL
%	NULL
PAGE	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
analyses	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
IxBa-	NULL
and	NULL
RelA-specific	NULL
antisera	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Physical	NULL
association	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
RelA	NULL
with	NULL
p100	NULL
,	NULL
p105	NULL
,	NULL
and	NULL
IxBa	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
incubated	NULL
with	NULL
either	NULL
preimmune	NULL
serum	NULL
or	NULL
RelA-specific	NULL
antiserum	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
then	NULL
divided	NULL
into	NULL
three	NULL
aliquots	NULL
,	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
peptide-specific	NULL
antisera	NULL
recognizing	NULL
the	NULL
N	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
)	NULL
of	NULL
p100	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
the	NULL
N	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
)	NULL
of	NULL
p105	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
amino	NULL
acids	NULL
289-317	NULL
)	NULL
of	NULL
IxBa	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Control	NULL
lanes	NULL
(	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
contained	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
p100	NULL
,	NULL
p105	NULL
,	NULL
and	NULL
IxBa	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Distinct	NULL
dynamics	NULL
for	NULL
RelA-IxBa	NULL
and	NULL
RelA-p100	NULL
complex	NULL
disassembly	NULL
in	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
140	NULL
units/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
followed	NULL
by	NULL
the	NULL
preparation	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
.	NULL

These	NULL
extracts	NULL
(	NULL
400	NULL
ug	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
either	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p100	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
and	NULL
analyzed	NULL
on	NULL
SDS/8.75	NULL
%	NULL
PAGE	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
the	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
RelA	NULL
.	NULL

1348	NULL
Biochemistry	NULL
:	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

interaction	NULL
,	NULL
which	NULL
critically	NULL
involves	NULL
inhibitor	NULL
masking	NULL
of	NULL
the	NULL
NLS	NULL
present	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
RelA	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
the	NULL
interactions	NULL
of	NULL
p100	NULL
and	NULL
p105	NULL
with	NULL
RelA	NULL
persisted	NULL
despite	NULL
deletion	NULL
of	NULL
the	NULL
NLS	NULL
of	NULL
RelA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RelA-IxBa	NULL
and	NULL
RelA-p100	NULL
Cytoplasmic	NULL
Complexes	NULL
Are	NULL
Differentially	NULL
Regulated	NULL
After	NULL
TNF-a	NULL
Stimulation	NULL
.	NULL

To	NULL
further	NULL
compare	NULL
and	NULL
contrast	NULL
the	NULL
biological	NULL
actions	NULL
of	NULL
IxBa	NULL
and	NULL
p100	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
dynamics	NULL
of	NULL
RelA-IxBa	NULL
and	NULL
RelA	NULL
,	NULL
p100	NULL
complex	NULL
disassembly	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

IxBa	NULL
,	NULL
p100	NULL
,	NULL
and	NULL
associated	NULL
proteins	NULL
were	NULL
first	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
antisera	NULL
against	NULL
either	NULL
IxBa	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
p100	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
coimmunoprecipitated	NULL
RelA	NULL
by	NULL
immunoblotting	NULL
with	NULL
RelA-specific	NULL
antiserum	NULL
.	NULL

As	NULL
predicted	NULL
from	NULL
the	NULL
degra-dative	NULL
fate	NULL
of	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
detection	NULL
of	NULL
RelA	NULL
was	NULL
lost	NULL
30	NULL
min	NULL
after	NULL
TNF-a	NULL
addition	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
but	NULL
this	NULL
immunoreactive	NULL
species	NULL
reappeared	NULL
at	NULL
2	NULL
hr	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
reflecting	NULL
the	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
IxBa	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

This	NULL
dynamic	NULL
change	NULL
in	NULL
IxBa	NULL
expression	NULL
precisely	NULL
correlates	NULL
with	NULL
the	NULL
transient	NULL
nuclear	NULL
translocation	NULL
of	NULL
RelA	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
association	NULL
of	NULL
RelA	NULL
and	NULL
p100	NULL
was	NULL
not	NULL
significantly	NULL
altered	NULL
even	NULL
after	NULL
2	NULL
hr	NULL
of	NULL
TNF-a	NULL
stimulation	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

p100	NULL
Exhibits	NULL
Potent	NULL
IxB-Like	NULL
Activity	NULL
in	NULL
Vivo	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
interaction	NULL
of	NULL
RelA	NULL
with	NULL
p100	NULL
and	NULL
p105	NULL
was	NULL
functionally	NULL
significant	NULL
in	NULL
vivo	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
HIV	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
together	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
RelA	NULL
,	NULL
IxBa	NULL
,	NULL
p100	NULL
,	NULL
and	NULL
p105	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
various	NULL
combinations	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Whereas	NULL
RelA	NULL
potently	NULL
activated	NULL
«	NULL
B-directed	NULL
transcription	NULL
from	NULL
the	NULL
HIV	NULL
«	NULL
B-CAT	NULL
reporter	NULL
(	NULL
>	NULL
250-fold	NULL
)	NULL
,	NULL
coexpression	NULL
of	NULL
RelA	NULL
with	NULL
either	NULL
p100	NULL
or	NULL
IxBa	NULL
significantly	NULL
inhibited	NULL
activation	NULL
.	NULL

Only	NULL
modest	NULL
inhibitory	NULL
effects	NULL
were	NULL
obtained	NULL
after	NULL
cotransfection	NULL
of	NULL
p105	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
ankyrin	NULL
motif-rich	NULL
domain	NULL
of	NULL
p100	NULL
[	NULL
p100	NULL
(	NULL
1-455	NULL
)	NULL
]	NULL
,	NULL
or	NULL
coexpression	NULL
of	NULL
RelA	NULL
with	NULL
the	NULL
equivalent	NULL
of	NULL
the	NULL
posttranslationally	NULL
cleaved	NULL
form	NULL
of	NULL
p100	NULL
(	NULL
p52	NULL
)	NULL
,	NULL
which	NULL
also	NULL
lacks	NULL
the	NULL
ankyrin	NULL
motif-rich	NULL
domain	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
near	NULL
complete	NULL
loss	NULL
of	NULL
these	NULL
inhibitory	NULL
effects	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

p100	NULL
Inhibition	NULL
of	NULL
RelA	NULL
Function	NULL
Is	NULL
Correlated	NULL
with	NULL
Cytoplasmic	NULL
Retention	NULL
of	NULL
RelA	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
p100	NULL
regulated	NULL
RelA	NULL
activity	NULL
by	NULL
altering	NULL
its	NULL
subcellular	NULL
distribution	NULL
,	NULL
indirect	NULL
immunofluorescence	NULL
studies	NULL
were	NULL
performed	NULL
in	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Since	NULL
wild-type	NULL
RelA	NULL
can	NULL
induce	NULL
endogenous	NULL
IxBa	NULL
expression	NULL
leading	NULL
to	NULL
cytoplasmic	NULL
trapping	NULL
of	NULL
RelA	NULL
(	NULL
19	NULL
)	NULL
,	NULL
an	NULL
N-terminal	NULL
truncation	NULL
mutant	NULL
of	NULL
RelA	NULL
[	NULL
p65	NULL
(	NULL
41-551	NULL
)	NULL
]	NULL
that	NULL
lacks	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
16	NULL
)	NULL
but	NULL
retains	NULL
the	NULL
capacity	NULL
to	NULL
bind	NULL
to	NULL
p100	NULL
and	NULL
IxBa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
p65	NULL
(	NULL
41-551	NULL
)	NULL
mutant	NULL
alone	NULL
revealed	NULL
a	NULL
predominantly	NULL
nuclear	NULL
pattern	NULL
of	NULL
fluorescence	NULL
(	NULL
Fig	NULL
.	NULL

300	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
3a	NULL
)	NULL
while	NULL
coexpression	NULL
of	NULL
this	NULL
truncated	NULL
form	NULL
of	NULL
RelA	NULL
with	NULL
IxBa	NULL
yielded	NULL
a	NULL
nuclear-excluded	NULL
pattern	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
coexpression	NULL
of	NULL
this	NULL
RelA	NULL
mutant	NULL
with	NULL
p100	NULL
produced	NULL
a	NULL
cytoplasmic	NULL
pattern	NULL
of	NULL
RelA	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3¢c	NULL
)	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
their	NULL
inability	NULL
to	NULL
inhibit	NULL
RelA	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
neither	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
p100	NULL
(	NULL
1-455	NULL
)	NULL
nor	NULL
p52	NULL
reproduced	NULL
this	NULL
cytoplasmic	NULL
retention	NULL
pattern	NULL
of	NULL
RelA	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
d	NULL
and	NULL
e	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
p100	NULL
and	NULL
NF-xB2	NULL
mRNA	NULL
Are	NULL
Induced	NULL
by	NULL
RelA	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
capable	NULL
of	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
one	NULL
of	NULL
its	NULL
own	NULL
inhibitors	NULL
,	NULL
IxBa	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Since	NULL
p100	NULL
is	NULL
also	NULL
an	NULL
immediate-early	NULL
activation	NULL
gene	NULL
product	NULL
(	NULL
30	NULL
)	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
cytoplasmic	NULL
retention	NULL
and	NULL
functional	NULL
inhibition	NULL
of	NULL
RelA	NULL
(	NULL
refs	NULL
.	NULL

21	NULL
and	NULL
22	NULL
;	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
immunoblotting	NULL
studies	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
investigate	NULL
whether	NULL
p100	NULL
protein	NULL
expression	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
RelA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
parental	NULL
pCMV4	NULL
vector	NULL
or	NULL
vectors	NULL
encoding	NULL
various	NULL
Rel	NULL
proteins	NULL
including	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
c-Rel	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
virtually	NULL
no	NULL
p100	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
pCMV4	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
c-Rel	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
transfection	NULL
of	NULL
RelA	NULL
markedly	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
p100	NULL
protein	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
this	NULL
induction	NULL
of	NULL
p100	NULL
by	NULL
RelA	NULL
could	NULL
be	NULL
significantly	NULL
inhibited	NULL
by	NULL
cotransfection	NULL
of	NULL
IxBa	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
wild-type	NULL
RelA	NULL
,	NULL
deletion	NULL
mutants	NULL
of	NULL
RelA	NULL
lacking	NULL
either	NULL
the	NULL
DNA-binding	NULL
[	NULL
p65	NULL
(	NULL
41-551	NULL
)	NULL
]	NULL
or	NULL
the	NULL
transactivation	NULL
[	NULL
p65	NULL
(	NULL
1-312	NULL
)	NULL
]	NULL
domains	NULL
failed	NULL
to	NULL
induce	NULL
p100	NULL
protein	NULL
expression	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
of	NULL
RelA	NULL
induction	NULL
of	NULL
p100	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
were	NULL
entirely	NULL
recapitulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B2	NULL
mRNA	NULL
expression	NULL
as	NULL
measured	NULL
in	NULL
RNase	NULL
protection	NULL
studies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
an	NULL
IxBa-independent	NULL
mechanism	NULL
of	NULL
NF-KB	NULL
regulation	NULL
in	NULL
vivo	NULL
involving	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
product	NULL
,	NULL
p100	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
two	NULL
recent	NULL
studies	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
RelA	NULL
is	NULL
physically	NULL
associated	NULL
with	NULL
both	NULL
p100	NULL
and	NULL
p105	NULL
as	NULL
well	NULL
as	NULL
IxBa	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
unstimulated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
p100	NULL
,	NULL
like	NULL
IkBa	NULL
,	NULL
potently	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
RelA	NULL
.	NULL

However	NULL
,	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
p105	NULL
produces	NULL
curiously	NULL
less	NULL
inhibition	NULL
.	NULL

At	NULL
present	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
these	NULL
differences	NULL
in	NULL
p100-	NULL
and	NULL
p105-mediated	NULL
inhibition	NULL
of	NULL
RelA	NULL
action	NULL
remains	NULL
unknown	NULL
.	NULL

However	NULL
,	NULL
this	NULL
finding	NULL
may	NULL
have	NULL
important	NULL
implications	NULL
for	NULL
the	NULL
multiple	NULL
intracellular	NULL
mechanisms	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
regulating	NULL
the	NULL
potent	NULL
transcriptional	NULL
activity	NULL
of	NULL
RelA	NULL
.	NULL

A	NULL
2501	NULL
2007	NULL
1507	NULL
1007	NULL
Fold	NULL
Activation	NULL
50	NULL
0	NULL
T-	NULL
~T	NULL
~T	NULL
--	NULL
-n	NULL
*	NULL
*s	NULL
``	NULL
0	NULL
*e	NULL
t	NULL
t	NULL
,	NULL
4	NULL
4oo	NULL
)	NULL
%	NULL
|B	NULL
0	NULL
bk	NULL
?	NULL

04	NULL
}	NULL
0an	NULL
04250	NULL
,	NULL
043200	NULL
%	NULL
,	NULL
°C	NULL
Kos	NULL
$	NULL
z	NULL
z	NULL
C	NULL
4	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
RelA-mediated	NULL
transcriptional	NULL
activation	NULL
by	NULL
p100	NULL
in	NULL
vivo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
vectors	NULL
alone	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
(	NULL
2	NULL
ug	NULL
of	NULL
each	NULL
)	NULL
together	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RelA	NULL
was	NULL
cotransfected	NULL
with	NULL
various	NULL
truncated	NULL
forms	NULL
of	NULL
p100	NULL
including	NULL
p100	NULL
(	NULL
1-455	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
N-terminal	NULL
455	NULL
amino	NULL
acids	NULL
and	NULL
lacks	NULL
the	NULL
C-terminal	NULL
ankyrin	NULL
motif	NULL
repeat	NULL
domain	NULL
,	NULL
and	NULL
p52	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
447-amino-acid-long	NULL
peptide	NULL
that	NULL
approximates	NULL
the	NULL
physiologically	NULL
cleaved	NULL
form	NULL
of	NULL
p100	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
measured	NULL
48	NULL
hr	NULL
after	NULL
transfection	NULL
and	NULL
are	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
enzymatic	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
.	NULL

Biochemistry	NULL
:	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

p65	NULL
(	NULL
41-551	NULL
)	NULL
+	NULL
p100	NULL
(	NULL
1-455	NULL
)	NULL
p65	NULL
(	NULL
41-551	NULL
)	NULL
+p52	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
1349	NULL
pCMV4+p100	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
p100	NULL
inhibits	NULL
nuclear	NULL
expression	NULL
of	NULL
RelA	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
N-terminal	NULL
truncation	NULL
mutant	NULL
of	NULL
RelA	NULL
,	NULL
p65	NULL
(	NULL
41-551	NULL
)	NULL
,	NULL
alone	NULL
(	NULL
a	NULL
)	NULL
or	NULL
with	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
b	NULL
)	NULL
,	NULL
p100	NULL
(	NULL
c	NULL
)	NULL
,	NULL
p100	NULL
(	NULL
1-455	NULL
)	NULL
(	NULL
d	NULL
)	NULL
,	NULL
or	NULL
p52	NULL
(	NULL
e	NULL
)	NULL
or	NULL
,	NULL
as	NULL
an	NULL
antibody	NULL
specificity	NULL
control	NULL
,	NULL
with	NULL
p100	NULL
alone	NULL
(	NULL
f	NULL
)	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
antiserum	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
RelA	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
indirect	NULL
immunofluorescence	NULL
staining	NULL
using	NULL
Texas	NULL
Red-conjugated	NULL
donkey	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Although	NULL
both	NULL
IxBa	NULL
and	NULL
p100	NULL
function	NULL
as	NULL
important	NULL
cytoplasmic	NULL
inhibitors	NULL
of	NULL
RelA	NULL
,	NULL
several	NULL
fundamental	NULL
differences	NULL
exist	NULL
regarding	NULL
their	NULL
mechanism	NULL
of	NULL
action	NULL
and	NULL
regulation	NULL
.	NULL

Our	NULL
present	NULL
studies	NULL
coupled	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
(	NULL
20	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
fraction	NULL
of	NULL
IxBa	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
after	NULL
cellular	NULL
activation	NULL
with	NULL
TNF-a	NULL
.	NULL

This	NULL
phosphorylation	NULL
event	NULL
appears	NULL
to	NULL
lead	NULL
to	NULL
enhanced	NULL
degradation	NULL
of	NULL
the	NULL
IxBa	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
whether	NULL
the	NULL
dissociation	NULL
of	NULL
IxBa	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
forms	NULL
an	NULL
intermediate	NULL
step	NULL
between	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
or	NULL
whether	NULL
degradation	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
release	NULL
,	NULL
or	NULL
even	NULL
perhaps	NULL
phosphorylation	NULL
,	NULL
given	NULL
the	NULL
incompleteness	NULL
of	NULL
the	NULL
latter	NULL
modification	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
TNF-a-induced	NULL
release	NULL
of	NULL
«	NULL
Ba	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
this	NULL
cytokine	NULL
does	NULL
not	NULL
promote	NULL
the	NULL
dissociation	NULL
of	NULL
p100	NULL
from	NULL
RelA	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
cytoplasmic	NULL
p100-RelA	NULL
complex	NULL
is	NULL
subject	NULL
to	NULL
an	NULL
alternate	NULL
form	NULL
of	NULL
regulation	NULL
.	NULL

Since	NULL
p52	NULL
,	NULL
the	NULL
processed	NULL
form	NULL
of	NULL
p100	NULL
,	NULL
continues	NULL
to	NULL
associate	NULL
with	NULL
p65	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
one	NULL
mechanism	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
p100-RelA	NULL
complex	NULL
may	NULL
involve	NULL
physiological	NULL
processing	NULL
of	NULL
p100	NULL
to	NULL
p52	NULL
.	NULL

This	NULL
processing	NULL
results	NULL
in	NULL
removal	NULL
of	NULL
the	NULL
C-terminal	NULL
ankyrin	NULL
motifs	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
p100	NULL
inhibition	NULL
of	NULL
RelA	NULL
function	NULL
but	NULL
not	NULL
its	NULL
assembly	NULL
with	NULL
RelA	NULL
.	NULL

In	NULL
the	NULL
1	NULL
2	NULL
3	NULL
71	NULL
f	NULL
?	NULL

(	NULL
‘	NULL
3	NULL
‘	NULL
7	NULL
8	NULL
9	NULL
Lo	NULL
T	NULL
d	NULL
I	NULL
116	NULL
-	NULL
ge	NULL
-	NULL
-	NULL
<	NULL
p100	NULL
>	NULL
to	NULL
84	NULL
58	NULL
-	NULL
<	NULL
p52	NULL
>	NULL
3	NULL
»	NULL
&	NULL
C3	NULL
6	NULL
.	NULL

0	NULL
,	NULL
62	NULL
62	NULL
6	NULL
.	NULL

Go	NULL
&	NULL
C	NULL
4	NULL
%	NULL
,	NULL
ns	NULL
%	NULL
J	NULL
¥	NULL
<	NULL
¥	NULL
190	NULL
,	NULL
¢	NULL
3,2	NULL
zZ	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
NF-	NULL
«	NULL
B	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
endogenous	NULL
p100	NULL
protein	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
various	NULL
Rel-related	NULL
proteins	NULL
on	NULL
p100	NULL
protein	NULL
expression	NULL
are	NULL
shown	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
parental	NULL
pCMV4	NULL
vector	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
or	NULL
the	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
Rel-related	NULL
polypeptides	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
48	NULL
hr	NULL
after	NULL
transfection	NULL
and	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
and	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
peptide-specific	NULL
antiserum	NULL
recognizing	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
human	NULL
p100	NULL
.	NULL

The	NULL
p100	NULL
polypeptide	NULL
and	NULL
its	NULL
processed	NULL
form	NULL
,	NULL
p52	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

case	NULL
of	NULL
IxBa	NULL
,	NULL
its	NULL
ankyrin	NULL
motifs	NULL
are	NULL
needed	NULL
both	NULL
for	NULL
functional	NULL
inhibition	NULL
and	NULL
for	NULL
physical	NULL
assembly	NULL
with	NULL
RelA	NULL
(	NULL
17	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
ankyrin	NULL
repeat	NULL
motifs	NULL
present	NULL
in	NULL
both	NULL
IxBa	NULL
and	NULL
p100	NULL
likely	NULL
mediate	NULL
protein-protein	NULL
interactions	NULL
that	NULL
serve	NULL
to	NULL
sequester	NULL
RelA	NULL
in	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
.	NULL

The	NULL
regulated	NULL
partitioning	NULL
of	NULL
factors	NULL
between	NULL
the	NULL
cytoplasm	NULL
and	NULL
nucleus	NULL
by	NULL
such	NULL
ankyrin	NULL
motif-containing	NULL
inhibitors	NULL
has	NULL
emerged	NULL
as	NULL
a	NULL
hallmark	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
IxBa	NULL
with	NULL
RelA	NULL
involves	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
inhibitor	NULL
to	NULL
the	NULL
NLS	NULL
of	NULL
RelA	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
NLS	NULL
in	NULL
RelA	NULL
results	NULL
in	NULL
sharply	NULL
diminished	NULL
IxBa	NULL
binding	NULL
and	NULL
IxBa-mediated	NULL
function	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NLS	NULL
deletion	NULL
in	NULL
RelA	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
its	NULL
interaction	NULL
with	NULL
p100	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Rather	NULL
,	NULL
distinct	NULL
sequences	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
both	NULL
RelA	NULL
and	NULL
p100	NULL
,	NULL
likely	NULL
those	NULL
responsible	NULL
for	NULL
dimerization	NULL
with	NULL
other	NULL
Rel	NULL
family	NULL
members	NULL
,	NULL
mediate	NULL
this	NULL
specific	NULL
factor-inhibitor	NULL
interaction	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
our	NULL
current	NULL
studies	NULL
indicate	NULL
that	NULL
RelA	NULL
autoregu-lates	NULL
the	NULL
expression	NULL
of	NULL
not	NULL
only	NULL
IxBa	NULL
(	NULL
19	NULL
)	NULL
but	NULL
also	NULL
p100	NULL
.	NULL

Specifically	NULL
,	NULL
transfection	NULL
of	NULL
RelA	NULL
induces	NULL
increased	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B2	NULL
mRNA	NULL
and	NULL
the	NULL
corresponding	NULL
p100	NULL
protein	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
similarly	NULL
regulated	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
the	NULL
p105	NULL
precursor	NULL
product	NULL
of	NULL
this	NULL
gene	NULL
also	NULL
antagonizes	NULL
RelA	NULL
function	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
albeit	NULL
weakly	NULL
in	NULL
our	NULL
studies	NULL
compared	NULL
to	NULL
p100	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
highlight	NULL
a	NULL
redundant	NULL
system	NULL
of	NULL
inducible	NULL
ankyrin-rich	NULL
cytoplasmic	NULL
inhibitors	NULL
that	NULL
provides	NULL
for	NULL
yet	NULL
additional	NULL
plasticity	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
occurring	NULL
in	NULL
response	NULL
to	NULL
various	NULL
immune	NULL
,	NULL
inflam-matory	NULL
,	NULL
or	NULL
developmental	NULL
stimuli	NULL
.	NULL

We	NULL
thank	NULL
Al	NULL
Baldwin	NULL
for	NULL
the	NULL
IxBa	NULL
cDNA	NULL
,	NULL
Steve	NULL
Ruben	NULL
and	NULL
Craig	NULL
Rosen	NULL
for	NULL
the	NULL
RelA	NULL
cDNA	NULL
,	NULL
Gary	NULL
Nabel	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
cDNA	NULL
,	NULL
Alain	NULL
Israél	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
cDNA	NULL
,	NULL
and	NULL
Kathleen	NULL
Raneses	NULL
and	NULL
Emily	NULL
Vance	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Training	NULL
Grant	NULL
ST32CAO9111	NULL
(	NULL
P.A.G	NULL
.	NULL
)	NULL

,	NULL
the	NULL
J.	NULL
David	NULL
Gladstone	NULL
Institute	NULL
(	NULL
W.C.G	NULL
.	NULL
)	NULL

,	NULL
and	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
(	NULL
D.W.B	NULL
.	NULL
)	NULL

.	NULL

1	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Cellular	NULL
Regulation	NULL
:	NULL
Hormonal	NULL
Control	NULL
Regulation	NULL
of	NULL
Gene	NULL
1350	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

Biochemistry	NULL
:	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

Transcription	NULL
,	NULL
eds	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
&	NULL
Foulkes	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
Elsevier/	NULL
North-Holland	NULL
,	NULL
Amsterdam	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

409-432	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kouriisky	NULL
,	NULL
P.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
348	NULL
,	NULL
76-80	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Haiker	NULL
,	NULL
M.	NULL
,	NULL
Bartsch	NULL
,	NULL
C.	NULL
,	NULL
Rothlisberger	NULL
,	NULL
U.	NULL
,	NULL
Lahm	NULL
,	NULL
H.-W.	NULL
,	NULL
Schlaeger	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
&	NULL
Schreidereit	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
966-970	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Dillon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-968	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Do-erre	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
1875-1879	NULL
.	NULL

Stephens	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Hiebsch	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Gilden	NULL
,	NULL
R.	NULL
V.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
6229-6232	NULL
.	NULL

Wilhelmsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Eggleton	NULL
,	NULL
K.	NULL
&	NULL
Temin	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

52	NULL
,	NULL
172-182	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
841-843	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1899-1913	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
&	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3	NULL
,	NULL
1339-1352	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J	NULL
.	NULL

$	NULL
.	NULL

,	NULL
Yuroch-ko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1281-1289	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Granzoso	NULL
,	NULL
G.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
2532-2536	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1912-1915	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Finco	NULL
,	NULL
T	NULL
.	NULL

$	NULL
.	NULL

,	NULL
Nantermet	NULL
,	NULL
P.	NULL
V.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
3301-3310	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
MacKichan	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
243-253	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
705-718	NULL
.	NULL

Fan	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
354	NULL
,	NULL
395-398	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
Davis	NULL
,	NULL
D.	NULL
,	NULL
Dahlback	NULL
,	NULL
H.	NULL
,	NULL
Jornvall	NULL
,	NULL
H.	NULL
&	NULL
Rus-sell	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
8222-8229	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
,	NULL
Steffen	NULL
,	NULL
A.	NULL
,	NULL
Litfin	NULL
,	NULL
M.	NULL
&	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5169-5181	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
,	NULL
Gulino	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Ruscetti	NULL
,	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
Virology	NULL
157	NULL
,	NULL
211-219	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
.	NULL

Bialojan	NULL
,	NULL
C.	NULL
&	NULL
Takai	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

256	NULL
,	NULL
248-252	NULL
.	NULL

Thevenin	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
Rieckman	NULL
,	NULL
P.	NULL
,	NULL
Fujiki	NULL
,	NULL
H.	NULL
,	NULL
Norcross	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Sporn	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Kehrl	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

9	NULL
,	NULL
793-800	NULL
.	NULL

~	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
685-695	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Israél	NULL
,	NULL
N.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.-G.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
&	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
195-203	NULL
.	NULL

Inoue	NULL
,	NULL
J.-I	NULL
.	NULL

,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Rashid	NULL
,	NULL
D.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
4333-4337	NULL
.	NULL

